LUPO, MARIA GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.653
EU - Europa 266
AS - Asia 127
AF - Africa 3
SA - Sud America 3
OC - Oceania 1
Totale 2.053
Nazione #
US - Stati Uniti d'America 1.652
IT - Italia 184
CN - Cina 106
FI - Finlandia 24
DE - Germania 13
UA - Ucraina 10
SE - Svezia 9
VN - Vietnam 9
FR - Francia 8
GB - Regno Unito 7
PK - Pakistan 5
BR - Brasile 3
EE - Estonia 3
HK - Hong Kong 2
KE - Kenya 2
LU - Lussemburgo 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BY - Bielorussia 1
CA - Canada 1
EG - Egitto 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.053
Città #
Fairfield 361
Houston 178
Ashburn 145
Woodbridge 145
Seattle 130
Cambridge 129
Wilmington 80
Chandler 74
Padova 71
Ann Arbor 43
San Diego 40
Medford 35
Princeton 35
Beijing 32
Des Moines 27
Roxbury 23
Helsinki 21
Ogden 14
Kharkiv 10
Dong Ket 9
Guangzhou 8
Shanghai 8
Hebei 7
Jinan 7
Milan 7
Aprilia 6
New York 6
Shenyang 5
Acqui Terme 4
Binasco 4
Chieti 4
Nanjing 4
Paris 4
Borås 3
Haikou 3
Legnaro 3
London 3
Marghera 3
Mestrino 3
Phoenix 3
São Paulo 3
Alessandria 2
Boardman 2
Changsha 2
Chengdu 2
Cosenza 2
Falkenstein 2
Falls Church 2
Fuzhou 2
Hong Kong 2
Isola del Giglio 2
Kunming 2
Lahore 2
Lanzhou 2
Lappeenranta 2
Manoppello 2
Paese 2
Pistoia 2
Reggio Calabria 2
Rome 2
Sahiwal 2
Tianjin 2
Trento 2
Treviso 2
Trieste 2
Udine 2
Acton 1
Ajman 1
Amsterdam 1
Auckland 1
Bassano del Grappa 1
Berlin 1
Bondeno 1
Brendola 1
Brindisi 1
Cairo 1
Carmignano di Brenta 1
Castegnero 1
Castellammare Di Stabia 1
Castellammare di Stabia 1
Chicago 1
Dalsjoefors 1
Dongguan 1
Dublin 1
Frankfurt am Main 1
Hangzhou 1
Hounslow 1
Jiaxing 1
Kilburn 1
Los Angeles 1
Montgomery 1
Motru 1
Nagold 1
Nanchang 1
New Delhi 1
Ningbo 1
Novate Milanese 1
Palermo 1
Palo Alto 1
Prescot 1
Totale 1.784
Nome #
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients 110
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals 101
Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: role of the small G protein Rac1 100
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 94
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake 94
Peptide modulators of Rac1/Tiam1 protein-protein interaction: An alternative approach for cardiovascular diseases 84
Monofunctional PtII Complexes Based on 8-Aminoquinoline: Synthesis and Pharmacological Characterization 83
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line 80
16p11.2 microdeletion syndrome: A case report 77
PCSK9 induces a pro-inflammatory response in macrophages 74
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia 74
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 73
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects 65
Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction associated fatty liver disease in mice. 64
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma 58
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE Study 56
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 56
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms and susceptibility to recurrent pregnancy loss 54
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients 52
The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance 51
Identification of patients with defects in the globin genes by analysing blood parameters and genetic study: Report of five cases 50
Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand 49
The Modulation of PCSK9 and LDLR by Supercritical CO2 Extracts of Mentha longifolia and Isolated Piperitone Oxide, an In Vitro Study 49
The emerging role of nutraceuticals in cardiovascular calcification: Evidence from preclinical and clinical studies 49
Naturally Occurring PCSK9 Inhibitors 45
Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis 43
Exploring the anticancer potential of diiron bis-cyclopentadienyl complexes with bridging hydrocarbyl ligands: Behavior in aqueous media and in vitro cytotoxicity 41
LEPTIN, RESISTIN, AND PCSK9 - THE ROLE OF STAT3 36
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study 34
PCSK9 promotes arterial medial calcification 30
NMR, LC-MS Characterization of Rydingia michauxii Extracts, Identification of Natural Products Acting as Modulators of LDLR and PCSK9 24
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line 23
Legacy perfluoro-alkyl substances impair LDL-cholesterol uptake independently from PCSK9-function 21
Pcsk9 induces rat smooth muscle cell proliferation and counteracts the pleiotropic effects of simvastatin 21
Identification of patients with defects in the globin genes 19
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma 17
Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results 17
Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the improve study 14
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9 9
Investigating the in vitro mode of action of okra (Abelmoschus esculentus) as hypocholesterolemic, anti-inflammatory, and antioxidant food 9
In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance 7
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease 4
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 3
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 2
Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation 2
Totale 2.118
Categoria #
all - tutte 10.125
article - articoli 10.125
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 13 41 29
2019/2020458 24 17 0 14 32 18 57 73 80 79 44 20
2020/2021422 43 45 30 41 14 22 6 42 70 26 57 26
2021/2022604 74 50 56 32 29 37 25 50 40 31 64 116
2022/2023287 67 9 9 11 40 30 10 36 35 5 34 1
2023/2024230 10 35 35 39 14 13 18 8 39 19 0 0
Totale 2.118